1998
DOI: 10.1073/pnas.95.13.7795
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine acts by A 1 receptors to stimulate release of prolactin from anterior-pituitaries in vitro

Abstract: Adenosine has been identified in the anterior pituitary gland and is secreted from cultured folliculostellate (FS) cells. To determine whether adenosine controls the secretion of anterior pituitary hormones in vitro, adenosine was incubated with anterior pituitaries. It stimulated prolactin (PRL) release at the lowest concentration used (10 ؊10 M); the stimulation peaked at 10 ؊8 M with a threefold increase in release and declined to minimal stimulation at 10 ؊4 and 10 ؊3M. Follicle-stimulating hormone release… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

1999
1999
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 16 publications
(14 reference statements)
0
18
0
Order By: Relevance
“…If we extrapolate this information to our results, we infer that both A1 and A2 receptors occur in the lactotroph since the biphasic effect on PRL secretion was observed at MECA doses of 1 to 10 µM. Recent studies have demonstrated an increase in PRL after administration of an A1 agonist (9) or A2A agonist and a decrease in PRL secretion after administration of an A1 agonist in vitro (10). These apparently contradictory results suggest that the differences may depend on the presence or absence of adenosine in the preparation and/or the type of agonist administered.…”
Section: Discussionmentioning
confidence: 88%
“…If we extrapolate this information to our results, we infer that both A1 and A2 receptors occur in the lactotroph since the biphasic effect on PRL secretion was observed at MECA doses of 1 to 10 µM. Recent studies have demonstrated an increase in PRL after administration of an A1 agonist (9) or A2A agonist and a decrease in PRL secretion after administration of an A1 agonist in vitro (10). These apparently contradictory results suggest that the differences may depend on the presence or absence of adenosine in the preparation and/or the type of agonist administered.…”
Section: Discussionmentioning
confidence: 88%
“…With their long cytoplasmic processes between other cell types, they are in an ideal position to play a role in intercellular communication mechanisms. Although FS cells do not secrete hormones, they are known to release biologically important factors and signaling molecules (e.g., IL-6, nitric oxide, vascular endothelial growth factor, basic fibroblast growth factor, follistatin) (14,29,36) and are responsive to central and peripheral stimuli [e.g., pituitary adenylate cyclaseactivating peptide (PACAP), vasoactive intestinal peptide, estrogens] (37-39) including immune factors (tumor necrosis factor ␣, transforming growth factor ␤3, IFN-␥) (40)(41)(42). Moreover and most remarkably, the FS cell network seems to provide a unique system of large-scale communication that may rapidly adjust cellular activities within the anterior pituitary.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that adenosine has a regulatory action on PRL release via the A 2 receptor, but not under basal conditions. This evidence is reinforced by the fact that two selective A 1 adenosine receptor antagonists and a highly specific A 2 receptor antagonist had no effect on basal PRL release (14).…”
Section: Discussionmentioning
confidence: 79%